Applied DNA Sciences Inc. (APDN)
NASDAQ: APDN
· Real-Time Price · USD
4.27
0.17 (4.15%)
At close: Oct 03, 2025, 3:59 PM
4.39
2.81%
After-hours: Oct 03, 2025, 07:56 PM EDT
4.15% (1D)
| Bid | 4.27 |
| Market Cap | 2.22M |
| Revenue (ttm) | 3.3M |
| Net Income (ttm) | -37.11M |
| EPS (ttm) | -57.12 |
| PE Ratio (ttm) | -0.07 |
| Forward PE | -0.05 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 4.36 |
| Volume | 215,350 |
| Avg. Volume (20D) | 420,307 |
| Open | 4.11 |
| Previous Close | 4.10 |
| Day's Range | 4.11 - 4.45 |
| 52-Week Range | 2.13 - 330.00 |
| Beta | 0.07 |
| Ex-Dividend Date | n/a |
About APDN
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol APDN
Website n/a
Applied DNA Sciences Inc. is scheduled to release its earnings on
Dec 16, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
3 days ago
-25.81%
Applied DNA Sciences shares are trading lower, pul...
Unlock content with
Pro Subscription
4 days ago
+26.33%
Applied DNA Sciences shares are trading higher after the company announced a private placement of up to $58M to launch a BNB treasury strategy and appointed Anthony Scaramucci as an adviser.
1 month ago · accessnewswire.com
Applied DNA Reports Third Quarter Fiscal 2025 Financial ResultsSTONY BROOK, NY / ACCESS Newswire / August 14, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a biotechnology company focused on providing nucleic acid production so...
2 months ago · accessnewswire.com
Applied DNA Regains Compliance with All Nasdaq Continued Listing RequirementsSTONY BROOK, NY / ACCESS Newswire / July 7, 2025 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (the "Company"), a leader in PCR-based DNA technologies, today announced that on July 2, 2025, it received w...